INKT ▲ +5.6% - MiNK Therapeutics, Inc.
$INKT - MiNK Therapeutics to Report Third Quarter 2026 Results and Outline Progress in Randomized Clinical Development and Scalable iNKT Cell Therapy
02-NOV-2026 04:35 PM ET
Share this post
More filings for $INKT
View full $INKT filing history →💬 Comments
Loading comments…
Leave a comment
